Pigmented demodicidosis - an under-recognized cause of facial hyperpigmentation
- PMID: 34897670
- DOI: 10.1111/ijd.15992
Pigmented demodicidosis - an under-recognized cause of facial hyperpigmentation
Abstract
Background: There is a paucity of data regarding demodicidosis-associated facial hyperpigmentation.
Objective: To delineate the clinical, dermoscopic, and histopathologic features of demodicidosis-associated facial hyperpigmentation.
Methods: Clinical and diagnostic data were collected from the medical files of patients who were referred to our outpatient dermatology clinic in 2006-2019 for evaluation of facial hyperpigmentation and were diagnosed with demodicidosis.
Results: The cohort included 19 patients (13 male) aged 42-76 years, all with Fitzpatrick skin type 3-4. All presented with mostly asymptomatic dusky, brown-gray, facial pigmentation, localized or diffuse with background erythema in 36.8% of cases, and skin roughness in 26.3%. Dermoscopy yielded characteristic findings of white gelatinous or opaque protrusions from hair follicles or infiltration of follicular openings with an amorphic material. A specific finding was perifollicular and reticulated pigmentation of the affected areas. Findings were confirmed on microscopic (n = 7) and histopathologic (n = 5) studies. Anti-demodectic treatment led to complete (73.6%) or partial (23.4%) resolution of pigmentation within 2 years.
Conclusion: We describe unique clinicopathological and dermoscopic findings associated with an under-recognized type of facial hyperpigmentation caused by demodex for which we propose the term "pigmented demodicidosis." Demodicidosis should be added to the list of causes of facial hyperpigmentation.
© 2021 the International Society of Dermatology.
References
-
- Taylor A, Pawaskar M, Taylor SL, et al. Prevalence of pigmentary disorders and their impact on quality of life: a prospective cohort study. Cosmet Dermatol 2008; 7: 164-168.
-
- Vashi NA, Wirya SA, Inyang M, et al. Facial hyperpigmentation in skin of color: special considerations and treatment. Am J Clin Dermatol 2017; 18: 215-230.
-
- Vashi NA, Kundu RV. Facial hyperpigmentation: causes and treatment. Br J Dermatol 2013; 169(Suppl 3): 41-56.
-
- Chaowattanapanit S, Silpa-archa N, Kohli I, et al. Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention. J Am Acad Dermatol 2017; 77: 607-621.
-
- Silpa-archa N, Kohli I, Chaowattanapanit S, et al. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol 2017; 77: 591-605.
MeSH terms
LinkOut - more resources
Full Text Sources
